CSPC Pharmaceutical Group Limited - Asset Resilience Ratio

Latest as of December 2025: 5.94%

CSPC Pharmaceutical Group Limited (CVG) has an Asset Resilience Ratio of 5.94% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CSPC Pharmaceutical Group Limited current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€2.78 Billion

≈ $3.25 Billion USD Cash + Short-term Investments

Total Assets

€46.70 Billion

≈ $54.59 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how CSPC Pharmaceutical Group Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see CSPC Pharmaceutical Group Limited (CVG) total assets.

Liquid Assets Composition Over Time

This chart breaks down CSPC Pharmaceutical Group Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of CSPC Pharmaceutical Group Limited to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€2.78 Billion	5.94%
Total Liquid Assets	€2.78 Billion	5.94%

Asset Resilience Insights

Limited Liquidity: CSPC Pharmaceutical Group Limited maintains only 5.94% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

CSPC Pharmaceutical Group Limited Industry Peers by Asset Resilience Ratio

Compare CSPC Pharmaceutical Group Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	5.33%
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
AstraZeneca PLC MX:AZNN	Drug Manufacturers - General	0.03%
Novartis AG ADR NYSE:NVS	Drug Manufacturers - General	0.06%
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd SHE:300357	Drug Manufacturers - General	9.91%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	6.46%

Annual Asset Resilience Ratio for CSPC Pharmaceutical Group Limited (2016–2025)

The table below shows the annual Asset Resilience Ratio data for CSPC Pharmaceutical Group Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	5.94%	€2.78 Billion ≈ $3.25 Billion	€46.70 Billion ≈ $54.59 Billion	+2.63pp
2024-12-31	3.32%	€1.47 Billion ≈ $1.72 Billion	€44.39 Billion ≈ $51.90 Billion	+0.99pp
2023-12-31	2.33%	€1.08 Billion ≈ $1.26 Billion	€46.28 Billion ≈ $54.11 Billion	-6.23pp
2022-12-31	8.56%	€3.57 Billion ≈ $4.18 Billion	€41.77 Billion ≈ $48.83 Billion	+4.40pp
2021-12-31	4.15%	€1.44 Billion ≈ $1.69 Billion	€34.74 Billion ≈ $40.62 Billion	-0.95pp
2020-12-31	5.11%	€1.54 Billion ≈ $1.79 Billion	€30.07 Billion ≈ $35.16 Billion	+5.10pp
2019-12-31	0.00%	€536.00K ≈ $626.64K	€26.32 Billion ≈ $30.77 Billion	+0.00pp
2018-12-31	0.00%	€441.76K ≈ $516.47K	€23.17 Billion ≈ $27.09 Billion	0.00pp
2017-12-31	0.00%	€611.66K ≈ $715.10K	€18.00 Billion ≈ $21.05 Billion	0.00pp
2016-12-31	0.00%	€466.51K ≈ $545.39K	€13.22 Billion ≈ $15.45 Billion	--

pp = percentage points

About CSPC Pharmaceutical Group Limited

F:CVG Germany Drug Manufacturers - General

Market Cap

$13.07 Billion

€11.18 Billion EUR

Market Cap Rank

#2235 Global

#465 in Germany

Share Price

€0.98

Change (1 day)

+1.71%

52-Week Range

€0.73 - €1.13

All Time High

€1.25